ID,Study,Author,year,Title,Marker,Sensitivity,Specificity,Size,Prevalence,Case,Control,Stage,is.size150,is.prevalence05,is.ed,is.icu,is.serum,is.wb,is.plasma,is.medical,is.surgical,is.as,is.eu,is.sponsorship,is.case.control,is.ps.norisk,is.it.norisk,is.rs.norisk,is.ft.norisk,is.ps.app,is.it.app,is.rs.app
1,"Otani, T., 2021","Otani, T. and Ichiba, T. and Seo, K. and Naito, H.",2021,Clinical prediction rule is more useful than qSOFA and the Sepsis-3 definition of sepsis for screening bacteremia,qSOFA,0.23,0.91,986,0.173427992,171,815,sepsis 3.0,1,0,1,0,0,0,0,1,0,1,0,0,1,,,,,,,
1,"Otani, T., 2021","Otani, T. and Ichiba, T. and Seo, K. and Naito, H.",2021,Clinical prediction rule is more useful than qSOFA and the Sepsis-3 definition of sepsis for screening bacteremia,SIRS,0.72,0.42,986,0.173427992,171,815,sepsis 3.0,1,0,1,0,0,0,0,1,0,1,0,0,1,,,,,,,
2,"Saito, A., 2023","Saito, A. and Osawa, I. and Shibata, J. and Sonoo, T. and Nakamura, K. and Goto, T.",2023,The prognostic utility of prehospital qSOFA in addition to emergency department qSOFA for sepsis in patients with suspected infection: A retrospective cohort study,qSOFA,0.9,0.28,2407,0.153302867,369,2038,sepsis 3.0,1,0,1,0,0,0,0,1,0,1,0,0,0,,,,,,,
3,"Ubaldo O.G.V., 2022",Ubaldo O.G.V.; Ang S.R.C.; Raymundo-Tayzon M.F.; Abad C.L.R.; Henson K.E.R.; Cinco J.E.L.,2022,A Prospective Cohort Study of the Quick Sequential Organ Failure Assessment (qSOFA) Score versus Systemic Inflammatory Response Syndrome (SIRS) Criteria in the Determination and Prognostication of Sepsis in a Philippine Tertiary Hospital.,qSOFA,0.463,0.955,295,0.322033898,95,200,sepsis 3.0,1,0,1,0,0,0,0,1,0,1,0,0,1,,,,,,,
3,"Ubaldo O.G.V., 2022",Ubaldo O.G.V.; Ang S.R.C.; Raymundo-Tayzon M.F.; Abad C.L.R.; Henson K.E.R.; Cinco J.E.L.,2022,A Prospective Cohort Study of the Quick Sequential Organ Failure Assessment (qSOFA) Score versus Systemic Inflammatory Response Syndrome (SIRS) Criteria in the Determination and Prognostication of Sepsis in a Philippine Tertiary Hospital.,SIRS,0.737,0.6,295,0.322033898,95,200,sepsis 3.0,1,0,1,0,0,0,0,1,0,1,0,0,1,,,,,,,
4,"Nasr El-Din A, 2021",Nasr El-Din A and Abdel-Gawad AR and Abdelgalil W and Fahmy NF,2021,Evaluation of sTREM1 and suPAR Biomarkers as Diagnostic and Prognostic Predictors in Sepsis Patients.,CRP,0.524,1,67,0.626865672,42,25,SIRS vs sepsis,0,1,0,1,1,1,0,1,0,0,0,0,1,,,,,,,
4,"Nasr El-Din A, 2021",Nasr El-Din A and Abdel-Gawad AR and Abdelgalil W and Fahmy NF,2021,Evaluation of sTREM1 and suPAR Biomarkers as Diagnostic and Prognostic Predictors in Sepsis Patients.,sTREM-1,1,1,67,0.626865672,42,25,SIRS vs sepsis,0,1,0,1,1,1,0,1,0,0,0,0,1,,,,,,,
5,"Pierre Hausfater, 2021","Pierre Hausfater, Neus Robert Boter, Cristian Morales Indiano, Marta Cancella de Abreu, Adria Mendoza Marin, Julie Pernet, Dolores Quesada, Iris Castro, Diana Careaga, Michel Arock, Liliana Tejidor, and Laetitia Velly",2021,Monocyte distribution width (MDW) performance as an early sepsis indicator,PCT,0.6,0.87,1160,0.124137931,144,1016,Sepsis 3.0,1,0,1,0,0,0,0,1,0,0,1,1,0,,,,,,,
5,"Pierre Hausfater, 2021","Pierre Hausfater, Neus Robert Boter, Cristian Morales Indiano, Marta Cancella de Abreu, Adria Mendoza Marin, Julie Pernet, Dolores Quesada, Iris Castro, Diana Careaga, Michel Arock, Liliana Tejidor, and Laetitia Velly",2021,Monocyte distribution width (MDW) performance as an early sepsis indicator,CRP,0.89,0.68,1160,0.124137931,144,1016,Sepsis 3.0,1,0,1,0,0,0,0,1,0,0,1,1,0,,,,,,,
6,"Dragana D. Arbutina, 2022","Dragana D. Arbutina, Ljiljana Milic, Vladica V. Cuk, Jovan T. Juloski, Radosav Radulovic, Ana Starcevic, and Aleksandar R. Karamarkovic",2022,Significance of Biomarkers in Early Diagnosis of Abdominal Sepsis ,CRP,0.8,0.6,100,0.55,55,45,SIRS vs sepsis,0,1,1,0,1,0,0,0,1,0,1,0,0,,,,,,,
6,"Dragana D. Arbutina, 2022","Dragana D. Arbutina, Ljiljana Milic, Vladica V. Cuk, Jovan T. Juloski, Radosav Radulovic, Ana Starcevic, and Aleksandar R. Karamarkovic",2022,Significance of Biomarkers in Early Diagnosis of Abdominal Sepsis ,PCT,0.24,0.85,100,0.55,55,45,SIRS vs sepsis,0,1,1,0,1,0,0,0,1,0,1,0,0,,,,,,,
7,"Baozhong Yu , 2022","Baozhong Yu , Maolin Chen, Ye Zhang, Yudan Cao, Jun Yang, Bing Wei, Junyu Wang ",2022,Diagnostic and Prognostic Value of Interleukin-6 in Emergency Department Sepsis Patients,IL-6,0.683,0.828,128,0.4921875,63,65,Sepsis 3.0,0,0,1,0,1,0,0,1,0,1,0,0,1,,,,,,,
8,"Yasemin Bozkurt Turan, 2023 ",Yasemin Bozkurt Turan ,2023,"The role of proadrenomedullin, interleukin 6 and CD64 in the diagnosis and prognosis of septic shock ",CD64,0.7949,0.8095,282,0.212765957,60,222,septic shock,1,0,0,1,1,0,0,0,1,1,1,0,0,,,,,,,
8,"Yasemin Bozkurt Turan, 2023 ",Yasemin Bozkurt Turan ,2023,"The role of proadrenomedullin, interleukin 6 and CD64 in the diagnosis and prognosis of septic shock ",IL-6,0.8462,0.1429,282,0.212765957,60,222,septic shock,1,0,0,1,1,0,0,0,1,1,1,0,0,,,,,,,
8,"Yasemin Bozkurt Turan, 2023 ",Yasemin Bozkurt Turan ,2023,"The role of proadrenomedullin, interleukin 6 and CD64 in the diagnosis and prognosis of septic shock ",PCT,0.7619,0.4359,282,0.212765957,60,222,septic shock,1,0,0,1,1,0,0,0,1,1,1,0,0,,,,,,,
8,"Yasemin Bozkurt Turan, 2023 ",Yasemin Bozkurt Turan ,2023,"The role of proadrenomedullin, interleukin 6 and CD64 in the diagnosis and prognosis of septic shock ",CRP,0.9524,0.1795,282,0.212765957,60,222,septic shock,1,0,0,1,1,0,0,0,1,1,1,0,0,,,,,,,
9,"Jeong YK, 2022",Jeong YK and Kim EY,2022,Predictive Role of Changes in Presepsin and Early Sepsis in ICU Patients After Abdominal Surgery.,presepsin,0.838,0.639,298,0.432885906,129,169,sepsis 3.0,1,0,0,1,1,0,0,0,1,1,0,0,1,,,,,,,
9,"Jeong YK, 2022",Jeong YK and Kim EY,2022,Predictive Role of Changes in Presepsin and Early Sepsis in ICU Patients After Abdominal Surgery.,PCT,0.667,0.89,298,0.432885906,129,169,sepsis 3.0,1,0,0,1,1,0,0,0,1,1,0,0,1,,,,,,,
10,"Lee JH, 2022",Lee JH and Kim SH and Jang JH and Park JH and Jo KM and No TH and Jang HJ and Lee HK,2022,Clinical usefulness of biomarkers for diagnosis and prediction of prognosis in sepsis and septic shock.,PCT,0.753,0.547,249,0.393574297,98,151,sepsis 3.0,1,0,1,0,1,0,0,1,0,1,0,0,1,,,,,,,
11,"Kyriazopoulou E, 2023",Kyriazopoulou E and Leventogiannis K and Tavoulareas G and Mainas E and Toutouzas K and Mathas C and Prekates A and Sakka V and Panagopoulos P and Syrigos K and Giamarellos-Bourboulis EJ,2023,Presepsin as a diagnostic and prognostic biomarker of severe bacterial infections and COVID-19.,presepsin,0.802,0.5,173,0.641618497,111,62,sepsis 3.0,1,1,1,0,0,0,1,1,0,0,1,0,1,,,,,,,
12,"Park JE, 2021",Park JE and Lee B and Yoon SJ and Park CM and Jung CW and Ahn MJ and Park HD and Hwang SY and Shin TG and Kang ES,2021,Complementary Use of Presepsin with the Sepsis-3 Criteria Improved Identification of High-Risk Patients with Suspected Sepsis.,presepsin,0.775,0.62,755,0.864900662,653,102,sepsis 3.0,1,1,1,1,0,0,1,1,0,1,0,0,1,,,,,,,
13,"Juneja D., 2023",Juneja D.; Jain N.; Singh O.; Goel A.; Arora S.,2023,"Comparison between presepsin, procalcitonin, and CRP as biomarkers to diagnose sepsis in critically ill patients",CRP,0.986,0.033,100,0.7,70,30,sepsis 3.0,0,1,0,1,1,0,0,1,0,1,0,0,1,,,,,,,
13,"Juneja D., 2023",Juneja D.; Jain N.; Singh O.; Goel A.; Arora S.,2023,"Comparison between presepsin, procalcitonin, and CRP as biomarkers to diagnose sepsis in critically ill patients",PCT,0.871,0.533,100,0.7,70,30,sepsis 3.0,0,1,0,1,1,0,0,1,0,1,0,0,1,,,,,,,
13,"Juneja D., 2023",Juneja D.; Jain N.; Singh O.; Goel A.; Arora S.,2023,"Comparison between presepsin, procalcitonin, and CRP as biomarkers to diagnose sepsis in critically ill patients",presepsin,0.771,0.667,100,0.7,70,30,sepsis 3.0,0,1,0,1,1,0,0,1,0,1,0,0,1,,,,,,,
14,"Lee, J., 2021","Lee, J. and Kim, S. and Kim, K.H. and Jeong, N.R. and Kim, S.C. and Oh, E.-J.",2021,The association between dynamic changes in serum presepsin levels and mortality in immunocompromised patients with sepsis: A prospective cohort study,presepsin,0.66,1,119,0.512605042,61,58,sepsis 3.0,0,1,0,1,1,0,1,1,0,1,0,0,1,,,,,,,
14,"Lee, J., 2021","Lee, J. and Kim, S. and Kim, K.H. and Jeong, N.R. and Kim, S.C. and Oh, E.-J.",2021,The association between dynamic changes in serum presepsin levels and mortality in immunocompromised patients with sepsis: A prospective cohort study,PCT,0.9,0.875,119,0.512605042,61,58,sepsis 3.0,0,1,0,1,1,0,1,1,0,1,0,0,1,,,,,,,
15,"Abdelshafey E.E., 2021",Abdelshafey E.E.; Nasa P.; Elgohary A.E.; Khalil M.F.; Rashwan M.A.; Ghezala H.B.; Tayar A.A.,2021,Role of presepsin for the diagnosis of sepsis and ICU mortality: A prospective controlled study,qSOFA,0.385,0.786,40,0.65,26,14,sepsis 3.0,0,1,0,1,0,0,0,1,0,0,0,0,1,,,,,,,
15,"Abdelshafey E.E., 2021",Abdelshafey E.E.; Nasa P.; Elgohary A.E.; Khalil M.F.; Rashwan M.A.; Ghezala H.B.; Tayar A.A.,2021,Role of presepsin for the diagnosis of sepsis and ICU mortality: A prospective controlled study,SIRS,0.692,0.571,40,0.65,26,14,sepsis 3.0,0,1,0,1,0,0,0,1,0,0,0,0,1,,,,,,,
15,"Abdelshafey E.E., 2021",Abdelshafey E.E.; Nasa P.; Elgohary A.E.; Khalil M.F.; Rashwan M.A.; Ghezala H.B.; Tayar A.A.,2021,Role of presepsin for the diagnosis of sepsis and ICU mortality: A prospective controlled study,presepsin,0.7308,0.9286,40,0.65,26,14,sepsis 3.0,0,1,0,1,0,0,0,1,0,0,0,0,1,,,,,,,
16,"Yonaha T, 2021","Yonaha T, Maruta T, Otao G, Igarashi K, Nagata S, Yano T, et al.",2021," The 
diagnostic and prognostic value of mature and total adrenomedullin for 
sepsis: a prospective observational study. ",PCT,0.946,0.589,98,0.571428571,56,42,sepsis 3.0,0,1,0,1,1,0,1,1,0,1,0,0,1,,,,,,,
16,"Yonaha T, 2021","Yonaha T, Maruta T, Otao G, Igarashi K, Nagata S, Yano T, et al.",2021," The 
diagnostic and prognostic value of mature and total adrenomedullin for 
sepsis: a prospective observational study. ",presepsin,0.889,0.491,98,0.571428571,56,42,sepsis 3.0,0,1,0,1,1,0,1,1,0,1,0,0,1,,,,,,,
16,"Yonaha T, 2021","Yonaha T, Maruta T, Otao G, Igarashi K, Nagata S, Yano T, et al.",2021," The 
diagnostic and prognostic value of mature and total adrenomedullin for 
sepsis: a prospective observational study. ",CRP,0.667,0.836,98,0.571428571,56,42,sepsis 3.0,0,1,0,1,1,0,1,1,0,1,0,0,1,,,,,,,
17,"Pham, H.M., 2023","Pham, H.M. and Nguyen, D.L.M. and Duong, M.C. and Tran, L.T. and Pham, T.T.N.",2023,Diagnostic Value of Neutrophil CD64 in Sepsis Patients in the Intensive Care Unit: A Cross-Sectional Study,CD64,0.899,0.857,104,0.663461538,69,35,sepsis 3.0,0,1,0,1,1,1,0,1,0,1,0,0,1,,,,,,,
17,"Pham, H.M., 2023","Pham, H.M. and Nguyen, D.L.M. and Duong, M.C. and Tran, L.T. and Pham, T.T.N.",2023,Diagnostic Value of Neutrophil CD64 in Sepsis Patients in the Intensive Care Unit: A Cross-Sectional Study,PCT,0.652,0.939,104,0.663461538,69,35,sepsis 3.0,0,1,0,1,1,1,0,1,0,1,0,0,1,,,,,,,
18,"Wang L., 2021",Wang L.; Yu L.; Yu W.; Zhan X.; Lv X.; Yi M.; Wu J.; Sun C.; Chen L.,2021,"Prospective comparison of neutrophil CD64, C-reactive protein and procalcitonin in the identification of ICU sepsis-3",PCT,0.6515,0.875,90,0.733333333,66,24,sepsis 3.0,0,1,0,1,1,1,0,1,0,1,0,0,1,,,,,,,
18,"Wang L., 2021",Wang L.; Yu L.; Yu W.; Zhan X.; Lv X.; Yi M.; Wu J.; Sun C.; Chen L.,2021,"Prospective comparison of neutrophil CD64, C-reactive protein and procalcitonin in the identification of ICU sepsis-3",CRP,0.8788,0.5833,90,0.733333333,66,24,sepsis 3.0,0,1,0,1,1,1,0,1,0,1,0,0,1,,,,,,,
18,"Wang L., 2021",Wang L.; Yu L.; Yu W.; Zhan X.; Lv X.; Yi M.; Wu J.; Sun C.; Chen L.,2021,"Prospective comparison of neutrophil CD64, C-reactive protein and procalcitonin in the identification of ICU sepsis-3",CD64,0.7727,0.9167,90,0.733333333,66,24,sepsis 3.0,0,1,0,1,1,1,0,1,0,1,0,0,1,,,,,,,
19,"Yin W.-P., 2021",Yin W.-P.; Li J.-B.; Zheng X.-F.; An L.; Shao H.; Li C.-S.,2021,Effect of neutrophil CD64 for diagnosing sepsis in emergency department,CD64,0.75,0.894,151,0.867549669,131,20,sepsis 3.0,1,1,1,0,1,0,0,1,0,1,0,0,1,,,,,,,
19,"Yin W.-P., 2021",Yin W.-P.; Li J.-B.; Zheng X.-F.; An L.; Shao H.; Li C.-S.,2021,Effect of neutrophil CD64 for diagnosing sepsis in emergency department,PCT,0.929,0.699,151,0.867549669,131,20,sepsis 3.0,1,1,1,0,1,0,0,1,0,1,0,0,1,,,,,,,
19,"Yin W.-P., 2021",Yin W.-P.; Li J.-B.; Zheng X.-F.; An L.; Shao H.; Li C.-S.,2021,Effect of neutrophil CD64 for diagnosing sepsis in emergency department,CRP,0.464,0.772,151,0.867549669,131,20,sepsis 3.0,1,1,1,0,1,0,0,1,0,1,0,0,1,,,,,,,
20,"Pandey K., 2021",Pandey K.; Malviya D.; Awasthi N.P.; Nath S.S.; Harjai M.,2021,Comparison of neutrophil CD64 and monocytic HLA-DR with existing biomarkers for the diagnosis and prognosis of sepsis,PCT,0.778,0.708,51,0.529411765,27,24,sepsis 3.0,0,1,0,1,1,0,0,1,0,1,0,0,1,,,,,,,
20,"Pandey K., 2021",Pandey K.; Malviya D.; Awasthi N.P.; Nath S.S.; Harjai M.,2021,Comparison of neutrophil CD64 and monocytic HLA-DR with existing biomarkers for the diagnosis and prognosis of sepsis,CRP,0.704,0.792,51,0.529411765,27,24,sepsis 3.0,0,1,0,1,1,0,0,1,0,1,0,0,1,,,,,,,
20,"Pandey K., 2021",Pandey K.; Malviya D.; Awasthi N.P.; Nath S.S.; Harjai M.,2021,Comparison of neutrophil CD64 and monocytic HLA-DR with existing biomarkers for the diagnosis and prognosis of sepsis,CD64,0.778,0.708,51,0.529411765,27,24,sepsis 3.0,0,1,0,1,1,0,0,1,0,1,0,0,1,,,,,,,
21,"Zhang W, 2022",Zhang W and Wang W and Hou W and Jiang C and Hu J and Sun L and Hu L and Wu J and Shang A,2022,"The diagnostic utility of IL-10, IL-17, and PCT in patients with sepsis infection.",PCT,0.7976,0.9136,165,0.509090909,84,81,sepsis 3.0,1,1,0,1,1,0,0,1,0,1,0,0,1,,,,,,,
21,"Zhang W, 2022",Zhang W and Wang W and Hou W and Jiang C and Hu J and Sun L and Hu L and Wu J and Shang A,2022,"The diagnostic utility of IL-10, IL-17, and PCT in patients with sepsis infection.",CRP,0.5357,0.9259,165,0.509090909,84,81,sepsis 3.0,1,1,0,1,1,0,0,1,0,1,0,0,1,,,,,,,
22,"Li, C.-H., 2022","Li, C.-H. and Seak, C.-J. and Chaou, C.-H. and Su, T.<e2><80><90>H. and Gao, S.-Y. and Chien, C.-Y. and Ng, C.-J.",2022,Comparison of the diagnostic accuracy of monocyte distribution width and procalcitonin in sepsis cases in the emergency department: a prospective cohort study,PCT,0.49,0.786,402,0.84079602,338,64,sepsis 3.0,1,1,1,0,1,0,0,1,0,1,0,0,1,,,,,,,
23,"J. Chen, 2021","J. Chen, Z. B. Huang, H. Li, X. Zheng, J. J. Chen, X. B. Wang, Z. P. Qian, X. X. Liu, X. G. Fan, X. W. Hu, C. J. Liao, L. Y. Long and Y. Huang",2021,Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter Study,presepsin,0.968,0.592,143,0.657342657,94,49,Sepsis 3.0,0,1,0,0,0,0,1,1,0,1,0,0,1,0,0,1,1,1,1,1
23,"J. Chen, 2021","J. Chen, Z. B. Huang, H. Li, X. Zheng, J. J. Chen, X. B. Wang, Z. P. Qian, X. X. Liu, X. G. Fan, X. W. Hu, C. J. Liao, L. Y. Long and Y. Huang",2021,Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter Study,PCT,0.553,0.816,143,0.657342657,94,49,Sepsis 3.0,0,1,0,0,0,0,1,1,0,1,0,0,1,0,0,1,1,1,1,1
23,"J. Chen, 2021","J. Chen, Z. B. Huang, H. Li, X. Zheng, J. J. Chen, X. B. Wang, Z. P. Qian, X. X. Liu, X. G. Fan, X. W. Hu, C. J. Liao, L. Y. Long and Y. Huang",2021,Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter Study,CRP,0.685,0.577,143,0.657342657,94,49,Sepsis 3.0,0,1,0,0,0,0,1,1,0,1,0,0,1,0,0,1,1,1,1,1
23,"J. Chen, 2021","J. Chen, Z. B. Huang, H. Li, X. Zheng, J. J. Chen, X. B. Wang, Z. P. Qian, X. X. Liu, X. G. Fan, X. W. Hu, C. J. Liao, L. Y. Long and Y. Huang",2021,Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter Study,sTREM-1,0.628,0.816,143,0.657342657,94,49,Sepsis 3.0,0,1,0,0,0,0,1,1,0,1,0,0,1,0,0,1,1,1,1,1
24,"W. P. Yin, 2021","W. P. Yin, J. B. Li, X. F. Zheng, L. An, H. Shao and C. S. Li",2021,Effect of neutrophil CD64 for diagnosing sepsis in emergency department,CD64,0.75,0.894,171,0.883040936,151,20,Sepsis 3.0,1,1,1,0,0,1,0,0,0,1,0,0,0,0,0,1,1,1,1,1
24,"W. P. Yin, 2021","W. P. Yin, J. B. Li, X. F. Zheng, L. An, H. Shao and C. S. Li",2021,Effect of neutrophil CD64 for diagnosing sepsis in emergency department,PCT,0.929,0.699,171,0.883040936,151,20,Sepsis 3.0,1,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,1,1,1
24,"W. P. Yin, 2021","W. P. Yin, J. B. Li, X. F. Zheng, L. An, H. Shao and C. S. Li",2021,Effect of neutrophil CD64 for diagnosing sepsis in emergency department,CRP,0.464,0.772,171,0.883040936,151,20,Sepsis 3.0,1,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,1,1,1
26,"A. F. Oduncu, 2021","A. F. Oduncu, G. S. K?yan and S. Yal??nl?",2021,"Comparison of qSOFA, SIRS, and NEWS scoring systems for diagnosis, mortality, and morbidity of sepsis in emergency department",qSOFA,0.23,0.9943,463,0.61987041,287,176,Sepsis 3.0,1,1,1,0,0,0,0,0,0,1,0,0,1,0,1,1,0,1,1,1
27,"Polilli E, 2020","Polilli E, 2020",2020,Comparison of Monocyte Distribution Width (MDW) and Procalcitonin for early recognition of sepsis,PCT,0.827,0.867,260,0.403846154,105,155,,1,0,0,0,0,0,0,0,0,0,1,0,1,0,1,1,1,1,1,1
28,"S. Spoto, 2020","S. Spoto, E. Nobile, E. P. R. Carn?, M. Fogolari, D. Caputo, L. De Florio, E. Valeriani, D. Benvenuto, S. Costantino, M. Ciccozzi and S. Angeletti",2020,Best diagnostic accuracy of sepsis combining SIRS criteria or qSOFA score with Procalcitonin and Mid-Regional pro-Adrenomedullin outside ICU,SIRS,0.7512,0.8431,209,0.80861244,169,40,Sepsis 3.0,1,1,0,0,0,0,0,0,1,0,1,0,0,0,1,1,1,1,1,1
28,"S. Spoto, 2020","S. Spoto, E. Nobile, E. P. R. Carn?, M. Fogolari, D. Caputo, L. De Florio, E. Valeriani, D. Benvenuto, S. Costantino, M. Ciccozzi and S. Angeletti",2020,Best diagnostic accuracy of sepsis combining SIRS criteria or qSOFA score with Procalcitonin and Mid-Regional pro-Adrenomedullin outside ICU,PCT,0.6794,0.9804,209,0.80861244,169,40,Sepsis 3.0,1,1,0,0,0,0,0,0,1,0,1,0,0,0,1,1,1,1,1,1
29,"J. S. Choi, 2020","J. S. Choi, B. R. Yoon, J. H. Shin, S. H. Lee, A. Y. Leem, M. S. Park, Y. S. Kim and K. S. Chung",2020,Clinical value of full-length tryptophanyl-tRNA synthetase for sepsis detection in critically ill patients - A retrospective clinical assessment,PCT,0.842,0.51,241,0.788381743,190,51,Sepsis 3.0,1,1,0,1,0,0,0,1,0,1,0,0,1,0,0,1,1,1,1,1
29,"J. S. Choi, 2020","J. S. Choi, B. R. Yoon, J. H. Shin, S. H. Lee, A. Y. Leem, M. S. Park, Y. S. Kim and K. S. Chung",2020,Clinical value of full-length tryptophanyl-tRNA synthetase for sepsis detection in critically ill patients - A retrospective clinical assessment,CRP,0.474,0.745,241,0.788381743,190,51,Sepsis 3.0,1,1,0,1,0,0,0,1,0,1,0,0,1,0,0,1,1,1,1,1
29,"J. S. Choi, 2020","J. S. Choi, B. R. Yoon, J. H. Shin, S. H. Lee, A. Y. Leem, M. S. Park, Y. S. Kim and K. S. Chung",2020,Clinical value of full-length tryptophanyl-tRNA synthetase for sepsis detection in critically ill patients - A retrospective clinical assessment,IL-6,0.563,0.686,241,0.788381743,190,51,Sepsis 3.0,1,1,0,1,0,0,0,1,0,1,0,0,1,0,0,1,1,1,1,1
30,"Y. D. Sui, 2020","Y. D. Sui, W. N. Xin and L. L. Feng",2020,"Comparison of the clinical application values of pct, hs-crp and saa detection in the early diagnosis of sepsis",PCT,0.7895,0.8824,36,0.472222222,17,19,Sepsis 3.0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,1,1,1
30,"Y. D. Sui, 2020","Y. D. Sui, W. N. Xin and L. L. Feng",2020,"Comparison of the clinical application values of pct, hs-crp and saa detection in the early diagnosis of sepsis",CRP,0.5217,0.6154,36,0.472222222,17,19,Sepsis 3.0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,1,1,1
31,"J. A. H. van Oers, 2020","J. A. H. van Oers, E. de Jong, H. Kemperman, A. R. J. Girbes and D. W. de Lange",2020,Diagnostic Accuracy of Procalcitonin and C-reactive Protein Is Insufficient to Predict Proven Infection: A Retrospective Cohort Study in Critically Ill Patients Fulfilling the Sepsis-3 Criteria,PCT,0.48,0.52,157,0.401273885,63,94,Sepsis 3.0,1,0,0,1,0,0,1,0,1,0,1,0,1,0,0,1,1,1,1,1
31,"J. A. H. van Oers, 2020","J. A. H. van Oers, E. de Jong, H. Kemperman, A. R. J. Girbes and D. W. de Lange",2020,Diagnostic Accuracy of Procalcitonin and C-reactive Protein Is Insufficient to Predict Proven Infection: A Retrospective Cohort Study in Critically Ill Patients Fulfilling the Sepsis-3 Criteria,CRP,0.51,0.54,157,0.401273885,63,94,Sepsis 3.0,1,0,0,1,0,0,1,0,1,0,1,0,1,0,0,1,1,1,1,1
32,"O. Ruangsomboon, 2020","O. Ruangsomboon, P. Panjaikaew, A. Monsomboon, T. Chakorn, C. Permpikul and C. Limsuwat",2020,Diagnostic and prognostic utility of presepsin for sepsis in very elderly patients in the emergency department,presepsin,0.835,0.622,250,0.556,139,111,Sepsis 3.0,1,1,1,0,1,0,0,0,0,1,0,0,1,1,0,1,1,1,1,1
32,"O. Ruangsomboon, 2020","O. Ruangsomboon, P. Panjaikaew, A. Monsomboon, T. Chakorn, C. Permpikul and C. Limsuwat",2020,Diagnostic and prognostic utility of presepsin for sepsis in very elderly patients in the emergency department,PCT,0.705,0.685,250,0.556,139,111,Sepsis 3.0,1,1,1,0,1,0,0,0,0,1,0,0,1,1,0,1,1,1,1,1
32,"O. Ruangsomboon, 2020","O. Ruangsomboon, P. Panjaikaew, A. Monsomboon, T. Chakorn, C. Permpikul and C. Limsuwat",2020,Diagnostic and prognostic utility of presepsin for sepsis in very elderly patients in the emergency department,CRP,0.784,0.667,250,0.556,139,111,Sepsis 3.0,1,1,1,0,1,0,0,0,0,1,0,0,1,1,0,1,1,1,1,1
33,"T. Katoch, 2020","T. Katoch, A. Singh, V. Suri, S. Sethi, N. Sachdeva and S. Naseem",2020,Diagnostic performance of biomarkers in maternal sepsis: A prospective observational study,PCT,0.8333,0.6667,30,0.6,18,12,Sepsis 3.0,0,1,0,0,1,0,0,0,1,1,0,0,1,1,0,1,1,1,1,1
33,"T. Katoch, 2020","T. Katoch, A. Singh, V. Suri, S. Sethi, N. Sachdeva and S. Naseem",2020,Diagnostic performance of biomarkers in maternal sepsis: A prospective observational study,CRP,0.7778,0.75,30,0.6,18,12,Sepsis 3.0,0,1,0,0,1,0,0,0,1,1,0,0,1,1,0,1,1,1,1,1
34,"Y. Li, 2020","Y. Li, K. Feng, W. Chen, J. Qiao and M. Zhao",2020,"High levels of CRP, PCT and HBP are collrelated with pneumonia secondary sepsis",PCT,0.6425,0.8269,84,0.416666667,35,49,Sepsis 3.0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,1,0,1,1,1
34,"Y. Li, 2020","Y. Li, K. Feng, W. Chen, J. Qiao and M. Zhao",2020,"High levels of CRP, PCT and HBP are collrelated with pneumonia secondary sepsis",CRP,0.7574,0.6911,84,0.416666667,35,49,Sepsis 3.0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,1,0,1,1,1
35,"(Ecoli) Y. Koizumi, 2020","(Ecoli) Y. Koizumi, D. Sakanashi, T. Ohno, A. Nakamura, A. Yamada, Y. Shibata, A. Shiota, H. Kato, M. Hagihara, N. Asai, M. Watarai, K. Murotani, Y. Yamagishi, H. Suematsu and H. Mikamo",2020,Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics,PCT,0.71,0.86,46,0.369565217,17,29,septic shock,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,1,1,1,1,1
35,"(Ecoli) Y. Koizumi, 2020","(Ecoli) Y. Koizumi, D. Sakanashi, T. Ohno, A. Nakamura, A. Yamada, Y. Shibata, A. Shiota, H. Kato, M. Hagihara, N. Asai, M. Watarai, K. Murotani, Y. Yamagishi, H. Suematsu and H. Mikamo",2020,Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics,CRP,0.57,0.89,46,0.369565217,17,29,septic shock,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,1,1,1,1,1
35,"(KP) Y. Koizumi, 2020","(KP) Y. Koizumi, D. Sakanashi, T. Ohno, A. Nakamura, A. Yamada, Y. Shibata, A. Shiota, H. Kato, M. Hagihara, N. Asai, M. Watarai, K. Murotani, Y. Yamagishi, H. Suematsu and H. Mikamo",2020,Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics,PCT,0.27,1,50,0.52,26,24,septic shock,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,1,1,1,1,1
35,"(KP) Y. Koizumi, 2020","(KP) Y. Koizumi, D. Sakanashi, T. Ohno, A. Nakamura, A. Yamada, Y. Shibata, A. Shiota, H. Kato, M. Hagihara, N. Asai, M. Watarai, K. Murotani, Y. Yamagishi, H. Suematsu and H. Mikamo",2020,Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics,CRP,0.4,0.78,50,0.52,26,24,septic shock,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,1,1,1,1,1
35,"(SA) Y. Koizumi, 2020","(SA) Y. Koizumi, D. Sakanashi, T. Ohno, A. Nakamura, A. Yamada, Y. Shibata, A. Shiota, H. Kato, M. Hagihara, N. Asai, M. Watarai, K. Murotani, Y. Yamagishi, H. Suematsu and H. Mikamo",2020,Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics,PCT,0.73,0.61,45,0.311111111,14,31,septic shock,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,1,1,1,1,1
35,"(SA) Y. Koizumi, 2020","(SA) Y. Koizumi, D. Sakanashi, T. Ohno, A. Nakamura, A. Yamada, Y. Shibata, A. Shiota, H. Kato, M. Hagihara, N. Asai, M. Watarai, K. Murotani, Y. Yamagishi, H. Suematsu and H. Mikamo",2020,Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics,CRP,0.71,0.7,45,0.311111111,14,31,septic shock,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,1,1,1,1,1
35,"(Sepidermitis) Y. Koizumi, 2020","(Sepidermitis) Y. Koizumi, D. Sakanashi, T. Ohno, A. Nakamura, A. Yamada, Y. Shibata, A. Shiota, H. Kato, M. Hagihara, N. Asai, M. Watarai, K. Murotani, Y. Yamagishi, H. Suematsu and H. Mikamo",2020,Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics,PCT,0.81,0.31,56,0.303571429,17,39,septic shock,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,1,1,1,1,1
35,"(Sepidermitis) Y. Koizumi, 2020","(Sepidermitis) Y. Koizumi, D. Sakanashi, T. Ohno, A. Nakamura, A. Yamada, Y. Shibata, A. Shiota, H. Kato, M. Hagihara, N. Asai, M. Watarai, K. Murotani, Y. Yamagishi, H. Suematsu and H. Mikamo",2020,Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics,CRP,0.69,0.6,56,0.303571429,17,39,septic shock,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,1,1,1,1,1
36,"A. Aliu-Bejta, 2020","A. Aliu-Bejta, A. Atelj, M. Kurshumliu, S. Dreshaj and B. Bar?i?",2020,Presepsin values as markers of severity of sepsis,presepsin,0.727,0.617,100,0.34,34,66,septic shock,0,0,0,1,1,0,0,0,0,0,1,0,1,0,0,1,1,1,1,1
37,"R. Tanvi, 2020",R. Tanvi and B. Dhanashree,2020,Procalcitonin and c-reactive protein: A predictor of bacteremia in sepsis,PCT,1,0.123,152,0.144736842,22,130,Sepsis 3.0 + bacteremia,1,0,0,1,0,0,1,0,0,1,0,0,1,0,0,1,1,1,1,1
37,"R. Tanvi, 2020",R. Tanvi and B. Dhanashree,2020,Procalcitonin and c-reactive protein: A predictor of bacteremia in sepsis,CRP,0.955,0.213,149,0.147651007,22,127,Sepsis 3.0 + bacteremia,0,0,0,1,0,0,1,0,0,1,0,0,1,0,0,1,1,1,1,1
38,"B. Yao, 2020","B. Yao, W. J. Liu, D. Liu, J. Y. Xing and L. J. Zhang",2020,Usefulness of sialic acid for diagnosis of sepsis in critically ill patients: a retrospective study,PCT,0.679,0.84,497,0.331991952,165,332,Sepsis 3.0,1,0,0,1,1,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
39,"(day 1) S. Wang, 2020","(day 1) S. Wang, W. Q. Ruan, Z. Yu, X. Zhao, Z. X. Chen and Q. Li",2020,Validity of presepsin for the diagnosis and prognosis of sepsis in elderly patients admitted to the Intensive Care Unit,presepsin,0.8205,0.8974,142,0.309859155,44,98,Sepsis 3.0,0,0,0,1,1,0,0,1,0,1,0,0,0,0,0,1,1,1,1,1
39,"(day 3) S. Wang, 2020","(day 3) S. Wang, W. Q. Ruan, Z. Yu, X. Zhao, Z. X. Chen and Q. Li",2020,Validity of presepsin for the diagnosis and prognosis of sepsis in elderly patients admitted to the Intensive Care Unit,presepsin,0.8333,0.6667,95,0.431578947,41,54,Sepsis 3.0,0,0,0,1,1,0,0,1,0,1,0,0,0,0,0,1,1,1,1,1
39,"(day 1) S. Wang, 2020","(day 1) S. Wang, W. Q. Ruan, Z. Yu, X. Zhao, Z. X. Chen and Q. Li",2020,Validity of presepsin for the diagnosis and prognosis of sepsis in elderly patients admitted to the Intensive Care Unit,PCT,0.8837,0.8367,142,0.309859155,44,98,Sepsis 3.0,0,0,0,1,1,0,0,1,0,1,0,0,0,0,0,1,1,1,1,1
39,"(day 3) S. Wang, 2020","(day 3) S. Wang, W. Q. Ruan, Z. Yu, X. Zhao, Z. X. Chen and Q. Li",2020,Validity of presepsin for the diagnosis and prognosis of sepsis in elderly patients admitted to the Intensive Care Unit,PCT,0.8889,0.6216,95,0.431578947,41,54,Sepsis 3.0,0,0,0,1,1,0,0,1,0,1,0,0,0,0,0,1,1,1,1,1
39,"(day 7) S. Wang, 2020","(day 7) S. Wang, W. Q. Ruan, Z. Yu, X. Zhao, Z. X. Chen and Q. Li",2020,Validity of presepsin for the diagnosis and prognosis of sepsis in elderly patients admitted to the Intensive Care Unit,PCT,0.7778,0.7027,91,0.417582418,38,53,Sepsis 3.0,0,0,0,1,1,0,0,1,0,1,0,0,0,0,0,1,1,1,1,1
39,"(day 1) S. Wang, 2020","(day 1) S. Wang, W. Q. Ruan, Z. Yu, X. Zhao, Z. X. Chen and Q. Li",2020,Validity of presepsin for the diagnosis and prognosis of sepsis in elderly patients admitted to the Intensive Care Unit,IL-6,0.775,0.6047,142,0.309859155,44,98,Sepsis 3.0,0,0,0,1,1,0,0,1,0,1,0,0,0,0,0,1,1,1,1,1
39,"(day 1) S. Wang, 2020","(day 1) S. Wang, W. Q. Ruan, Z. Yu, X. Zhao, Z. X. Chen and Q. Li",2020,Validity of presepsin for the diagnosis and prognosis of sepsis in elderly patients admitted to the Intensive Care Unit,CRP,0.7,0.7333,142,0.309859155,44,98,Sepsis 3.0,0,0,0,1,1,0,0,1,0,1,0,0,0,0,0,1,1,1,1,1
40,"X. Hou, 2020","X. Hou, C. Liu, H. Lian, Z. Xu, L. Ma, X. Zang, J. Sun, K. Jia and L. Cui",2020,"The value of neutrophil gelatinase-associated lipocalin and citrullinated alpha enolase peptide-1 antibody in diagnosis, classification, and prognosis for patients with sepsis",CRP,0.884,1,109,0.633027523,69,40,Sepsis 3.0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,1,1,1,1,1
40,"X. Hou, 2020","X. Hou, C. Liu, H. Lian, Z. Xu, L. Ma, X. Zang, J. Sun, K. Jia and L. Cui",2020,"The value of neutrophil gelatinase-associated lipocalin and citrullinated alpha enolase peptide-1 antibody in diagnosis, classification, and prognosis for patients with sepsis",PCT,0.942,0.75,109,0.633027523,69,40,Sepsis 3.0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,1,1,1,1,1
40,"X. Hou, 2020","X. Hou, C. Liu, H. Lian, Z. Xu, L. Ma, X. Zang, J. Sun, K. Jia and L. Cui",2020,"The value of neutrophil gelatinase-associated lipocalin and citrullinated alpha enolase peptide-1 antibody in diagnosis, classification, and prognosis for patients with sepsis",IL-6,0.783,0.95,109,0.633027523,69,40,Sepsis 3.0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,1,1,1,1,1
41,"J. Lee, 2020",J. Lee and J. U. Song,2020,Performance of a quick sofa-65 score as a rapid sepsis screening tool during initial emergency department assessment: A propensity score matching study,qSOFA,0.29,0.98,2441,0.382220401,933,1508,Sepsis 3.0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,1,1,0,1,1,1
41,"J. Lee, 2020",J. Lee and J. U. Song,2020,Performance of a quick sofa-65 score as a rapid sepsis screening tool during initial emergency department assessment: A propensity score matching study,SIRS,0.66,0.56,2441,0.382220401,933,1508,Sepsis 3.0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,1,1,0,1,1,1
42,"Karampelaa I, 2019","Karampelaa I, 2019",2019,Circulating eNampt and resistin as a proinflammatory duet predicting independently mortality in critically ill patients with sepsis A prospective observational study,PCT,0.6,0.828,102,0.411764706,42,60,SSh vs sepsis,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,1,1,1,1,1
42,"Karampelaa I, 2019","Karampelaa I, 2019",2019,Circulating eNampt and resistin as a proinflammatory duet predicting independently mortality in critically ill patients with sepsis A prospective observational study,CRP,0.8,0.69,102,0.411764706,42,60,SSh vs sepsis,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,1,1,1,1,1
42,"Karampelaa I, 2019","Karampelaa I, 2019",2019,Circulating eNampt and resistin as a proinflammatory duet predicting independently mortality in critically ill patients with sepsis A prospective observational study,IL-6,0.7,0.621,102,0.411764706,42,60,SSh vs sepsis,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,1,1,1,1,1
43,"Nakamura Y, 2019 (non-AKI)","Nakamura Y, 2019 (non-AKI)",2019,Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury,presepsin,0.809,0.832,340,0.138235294,47,293,sepsis without SKI vs non-sepsis,1,0,0,1,0,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
43,"Nakamura Y, 2019 (non-AKI)","Nakamura Y, 2019 (non-AKI)",2019,Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury,PCT,0.851,0.791,340,0.138235294,47,293,sepsis with AKI vs non sepsis,1,0,0,1,0,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
43,"Nakamura Y, 2019 (stage1)","Nakamura Y, 2019 (stage1)",2019,Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury,presepsin,0.833,0.691,226,0.212389381,48,178,sepsis with AKI vs non sepsis,1,0,0,1,0,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
43,"Nakamura Y, 2019 (stage1)","Nakamura Y, 2019 (stage1)",2019,Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury,PCT,0.833,0.916,226,0.212389381,48,178,sepsis with AKI vs non sepsis,1,0,0,1,0,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
43,"Nakamura Y, 2019 (stage2)","Nakamura Y, 2019 (stage2)",2019,Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury,presepsin,0.833,0.556,39,0.307692308,12,27,sepsis with AKI vs non sepsis,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
43,"Nakamura Y, 2019 (stage2)","Nakamura Y, 2019 (stage2)",2019,Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury,PCT,0.75,0.889,39,0.307692308,12,27,sepsis with AKI vs non sepsis,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
43,"Nakamura Y, 2019 (stage3)","Nakamura Y, 2019 (stage3)",2019,Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury,presepsin,0.897,0.597,101,0.386138614,39,62,sepsis with AKI vs non sepsis,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
43,"Nakamura Y, 2019 (stage3)","Nakamura Y, 2019 (stage3)",2019,Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury,PCT,0.872,0.935,101,0.386138614,39,62,sepsis with AKI vs non sepsis,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
44,"Yamamoto T, 2019","Yamamoto T, 2019",2019,Diagnostic accuracy of presepsin for sepsis by the new Sepsis-3 definitions,presepsin,0.86,0.93,91,0.681318681,62,29,,0,1,0,1,0,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
44,"Yamamoto T, 2019","Yamamoto T, 2019",2019,Diagnostic accuracy of presepsin for sepsis by the new Sepsis-3 definitions,PCT,0.86,0.91,91,0.681318681,62,29,,0,1,0,1,0,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
44,"Yamamoto T, 2019","Yamamoto T, 2019",2019,Diagnostic accuracy of presepsin for sepsis by the new Sepsis-3 definitions,CRP,0.9,0.89,91,0.681318681,62,29,,0,1,0,1,0,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
45,"Zhang Y, 2019","Zhang Y, 2019",2019,Diagnostic and predictive performance of biomarkers in patients with sepsis in an intensive care unit,PCT,0.6885,0.7174,180,0.466666667,84,96,SSh vs non-SSh,1,0,0,1,1,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
45,"Zhang Y, 2019","Zhang Y, 2019",2019,Diagnostic and predictive performance of biomarkers in patients with sepsis in an intensive care unit,IL-6,0.8,0.7097,180,0.466666667,84,96,SSh vs non-SSh,1,0,0,1,1,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
46,"Son J, 2019","Son J, 2019",2019,"Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions",IL-6,0.804,0.889,142,0.683098592,97,45,,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,1,1,1
47,"Sen P, 2019","Sen P, 2019",2019,Diagnostic and prognostic value of new bioscore in critically ill septic patients,CRP,0.647,0.508,226,0.663716814,150,76,,1,1,0,1,0,0,0,0,0,0,1,0,1,0,0,1,1,1,1,1
47,"Sen P, 2019","Sen P, 2019",2019,Diagnostic and prognostic value of new bioscore in critically ill septic patients,PCT,0.527,0.754,226,0.663716814,150,76,,1,1,0,1,1,0,0,0,0,0,1,0,1,0,0,1,1,1,1,1
48,"Jedynak M, 2019","Jedynak M, 2019",2019,"Diagnostic effectiveness of soluble triggering receptor expressed on myeloid cells-1 in sepsis, severe sepsis and septic shock.",PCT,0.88,0.46,54,0.592592593,32,22,SS vs NI-SIRS,0,1,0,1,1,0,0,0,0,0,1,0,0,0,0,1,1,1,1,1
48,"Jedynak M, 2019","Jedynak M, 2019",2019,"Diagnostic effectiveness of soluble triggering receptor expressed on myeloid cells-1 in sepsis, severe sepsis and septic shock.",CRP,0.88,0.86,54,0.592592593,32,22,SS vs NI-SIRS,0,1,0,1,1,0,0,0,0,0,1,0,0,0,0,1,1,1,1,1
48,"Jedynak M, 2019","Jedynak M, 2019",2019,"Diagnostic effectiveness of soluble triggering receptor expressed on myeloid cells-1 in sepsis, severe sepsis and septic shock.",IL-6,0.91,0.82,54,0.592592593,32,22,SS vs NI-SIRS,0,1,0,1,1,0,0,0,0,0,1,0,0,0,0,1,1,1,1,1
48,"Jedynak M, 2019","Jedynak M, 2019",2019,"Diagnostic effectiveness of soluble triggering receptor expressed on myeloid cells-1 in sepsis, severe sepsis and septic shock.",sTREM-1,0.63,0.82,54,0.592592593,32,22,SS vs NI-SIRS,0,1,0,1,1,0,0,0,0,0,1,0,0,0,0,1,1,1,1,1
49,"Gupta, 2019","Gupta, 2019",2019,Procalcitonin as a diagnostic biomarker of sepsis A tertiary care centre experience,PCT,0.985,0.8913,305,0.849180328,259,46,culture (+) sepsis vs non-sepsis,1,1,0,0,1,0,0,1,0,1,0,0,1,0,0,1,0,1,1,1
50,"Jereb M, 2019","Jereb M, 2019",2019,Usefulness of presepsin as diagnostic and prognostic marker of sepsis in daily clinical practice,presepsin,0.944,0.846,80,0.675,54,26,,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,1,1,1,1
51,"Kim SJ, 2019","Kim SJ, 2019",2019,Procalcitonin as a diagnostic marker for sepsis/septic shock in the emergency department; a study based on Sepsis-3 definition,PCT,0.748,0.638,866,0.668591224,579,287,,1,1,1,0,1,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
52,"C. Thiriet, 2019","C. Thiriet, K. Mahjoub, G. Courte, P. Labroca, A. Cravoisy, J. Lemarie, M. Conrad, L. Nace, P. E. Bollaert and S. Gibot",2019,Automated measurement of neutrophil CD64 expression for diagnosing sepsis in critically ill patients,CRP,0.677,0.771,72,0.555555556,40,32,Sepsis 3.0,0,1,0,1,1,0,0,0,1,0,1,0,1,0,0,1,1,1,1,1
52,"C. Thiriet, 2019","C. Thiriet, K. Mahjoub, G. Courte, P. Labroca, A. Cravoisy, J. Lemarie, M. Conrad, L. Nace, P. E. Bollaert and S. Gibot",2019,Automated measurement of neutrophil CD64 expression for diagnosing sepsis in critically ill patients,PCT,0.7,0.567,72,0.555555556,40,32,Sepsis 3.0,0,1,0,1,0,0,1,0,1,0,1,0,1,0,0,1,1,1,1,1
52,"C. Thiriet, 2019","C. Thiriet, K. Mahjoub, G. Courte, P. Labroca, A. Cravoisy, J. Lemarie, M. Conrad, L. Nace, P. E. Bollaert and S. Gibot",2019,Automated measurement of neutrophil CD64 expression for diagnosing sepsis in critically ill patients,CD64,0.781,0.7,72,0.555555556,40,32,Sepsis 3.0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,1,1,1,1
53,"G. F. Juro, 2019","G. F. Juro?, M. Tomi?i?, S. D. ?ari?, M. Peri? and D. Rogi?",2019,"Contribution of presepsin, procalcitonin and C-reactive protein to the SOFA score in early sepsis diagnosis in emergency abdominal surgical patients",presepsin,0.972,0.333,72,0.5,36,36,Sepsis 3.0,0,1,0,1,0,0,0,0,1,0,1,0,1,0,0,1,1,1,1,1
53,"G. F. Juro, 2019","G. F. Juro?, M. Tomi?i?, S. D. ?ari?, M. Peri? and D. Rogi?",2019,"Contribution of presepsin, procalcitonin and C-reactive protein to the SOFA score in early sepsis diagnosis in emergency abdominal surgical patients",PCT,0.972,0.167,72,0.5,36,36,Sepsis 3.0,0,1,0,1,0,0,0,0,1,0,1,0,1,0,0,1,1,1,1,1
53,"G. F. Juro, 2019","G. F. Juro?, M. Tomi?i?, S. D. ?ari?, M. Peri? and D. Rogi?",2019,"Contribution of presepsin, procalcitonin and C-reactive protein to the SOFA score in early sepsis diagnosis in emergency abdominal surgical patients",CRP,0.972,0.139,72,0.5,36,36,Sepsis 3.0,0,1,0,1,0,0,0,0,1,0,1,0,1,0,0,1,1,1,1,1
54,"D. W. Jekarl, 2019","D. W. Jekarl, J. Y. Kim, J. H. Ha, S. Lee, J. Yoo, M. Kim and Y. Kim",2019,"Diagnosis and Prognosis of Sepsis Based on Use of Cytokines, Chemokines, and Growth Factors",IL-6,0.675,0.955,160,0.5,80,80,Sepsis 3.0,1,1,1,1,1,0,0,0,0,1,0,1,0,0,0,1,1,1,1,1
55,"Z. Ye, 2019","Z. Ye, H. Zou, S. Liu, C. Mei, X. Chang, Z. Hu, H. Yang and Y. Wu",2019,Diagnostic performance of neutrophil CD64 index in patients with sepsis in the intensive care unit,CD64,0.83,0.88,62,0.564516129,35,27,Sepsis 3.0,0,1,0,1,0,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
55,"Z. Ye, 2019","Z. Ye, H. Zou, S. Liu, C. Mei, X. Chang, Z. Hu, H. Yang and Y. Wu",2019,Diagnostic performance of neutrophil CD64 index in patients with sepsis in the intensive care unit,CRP,0.74,0.86,62,0.564516129,35,27,Sepsis 3.0,0,1,0,1,0,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
55,"Z. Ye, 2019","Z. Ye, H. Zou, S. Liu, C. Mei, X. Chang, Z. Hu, H. Yang and Y. Wu",2019,Diagnostic performance of neutrophil CD64 index in patients with sepsis in the intensive care unit,PCT,0.77,0.81,62,0.564516129,35,27,Sepsis 3.0,0,1,0,1,0,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
56,"F. Guo, 2019","F. Guo, Y. C. Feng, G. Zhao, H. L. Wu, L. Xu, J. Zhao, J. Lv, S. T. Han, Y. C. Huang and X. M. Ma",2019,"The Leukocyte VCS Parameters Compared with Procalcitonin, Interleukin-6, and Soluble Hemoglobin Scavenger Receptor sCD163 for Prediction of Sepsis in Patients with Cirrhosis",PCT,0.778,0.93,154,0.350649351,54,100,Sepsis 3.0,1,0,1,0,1,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
56,"F. Guo, 2019","F. Guo, Y. C. Feng, G. Zhao, H. L. Wu, L. Xu, J. Zhao, J. Lv, S. T. Han, Y. C. Huang and X. M. Ma",2019,"The Leukocyte VCS Parameters Compared with Procalcitonin, Interleukin-6, and Soluble Hemoglobin Scavenger Receptor sCD163 for Prediction of Sepsis in Patients with Cirrhosis",IL-6,0.815,0.93,154,0.350649351,54,100,Sepsis 3.0,1,0,1,0,1,0,0,0,0,1,0,0,1,0,0,1,1,1,1,1
57,"J. Jiang, 2019","J. Jiang, H. Du, Y. Su, X. Li, J. Zhang, M. Chen, G. Ren, F. He and B. Niu",2019,Nonviral infection-related lymphocytopenia for the prediction of adult sepsis and its persistence indicates a higher mortality,PCT,0.8831,0.8439,100,0.77,77,23,Sepsis 3.0,0,1,0,1,0,0,0,0,0,1,0,1,1,0,0,1,1,1,1,1
58,"J. Contenti, 2019","J. Contenti, C. Occelli, F. Lemoel, P. Ferrari and J. Levraut",2019,Presepsin versus other biomarkers to predict sepsis and septic shock in patients with infection defined by Sepsis-3 criteria: the PREDI study of diagnostic accuracy,presepsin,0.62,0.72,359,0.690807799,248,111,Sepsis 3.0,1,1,1,0,0,0,0,0,0,0,1,1,1,0,0,1,0,1,1,1
58,"J. Contenti, 2019","J. Contenti, C. Occelli, F. Lemoel, P. Ferrari and J. Levraut",2019,Presepsin versus other biomarkers to predict sepsis and septic shock in patients with infection defined by Sepsis-3 criteria: the PREDI study of diagnostic accuracy,PCT,0.7,0.59,359,0.690807799,248,111,Sepsis 3.0,1,1,1,0,0,0,0,0,0,0,1,1,1,0,0,1,0,1,1,1
59,"D. W. Jekarl, 2019","D. W. Jekarl, S. Lee, M. Kim, Y. Kim, S. H. Woo and W. J. Lee",2019,Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3,PCT,0.845,0.466,248,0.745967742,185,63,Sepsis 3.0,1,1,1,0,0,1,0,0,0,1,0,0,1,0,0,1,1,1,1,1
59,"D. W. Jekarl, 2019","D. W. Jekarl, S. Lee, M. Kim, Y. Kim, S. H. Woo and W. J. Lee",2019,Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3,CRP,0.665,0.508,248,0.745967742,185,63,Sepsis 3.0,1,1,1,0,0,1,0,0,0,1,0,0,1,0,0,1,1,1,1,1
60,"(Euthyroid) A. S. Shirali, 2019","(Euthyroid) A. S. Shirali, J. X. Wu, C. Y. Zhu, A. Ocampo, C. H. Tseng, L. Du, M. J. Livhits, A. M. Leung and M. W. Yeh",2019,The Role of Serum Procalcitonin in Predicting Bacterial Sepsis in Patients With Hypothyroidism,PCT,0.59,0.81,217,0.451612903,98,119,Sepsis 3.0,1,0,0,0,1,0,0,1,0,0,0,0,1,0,0,1,0,1,1,1
60,"(MH) A. S. Shirali, 2019","(MH) A. S. Shirali, J. X. Wu, C. Y. Zhu, A. Ocampo, C. H. Tseng, L. Du, M. J. Livhits, A. M. Leung and M. W. Yeh",2019,The Role of Serum Procalcitonin in Predicting Bacterial Sepsis in Patients With Hypothyroidism,PCT,0.61,0.77,197,0.467005076,92,105,Sepsis 3.0,1,0,0,0,1,0,0,1,0,0,0,0,1,0,0,1,0,1,1,1
60,"(TT) A. S. Shirali, 2019","(TT) A. S. Shirali, J. X. Wu, C. Y. Zhu, A. Ocampo, C. H. Tseng, L. Du, M. J. Livhits, A. M. Leung and M. W. Yeh",2019,The Role of Serum Procalcitonin in Predicting Bacterial Sepsis in Patients With Hypothyroidism,PCT,0.53,0.81,84,0.428571429,36,48,Sepsis 3.0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,1,0,1,1,1
61,"Y. Zhou, 2019","Y. Zhou, Z. Liu, J. Huang, G. Li, F. Li, Y. Cheng, X. Xie and J. Zhang",2019,Usefulness of the heparin-binding protein level to diagnose sepsis and septic shock according to Sepsis-3 compared with procalcitonin and C reactive protein: a prospective cohort study in China,PCT,0.709,0.826,125,0.744,93,32,Sepsis 3.0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,1,0,1,1,1
61,"Y. Zhou, 2019","Y. Zhou, Z. Liu, J. Huang, G. Li, F. Li, Y. Cheng, X. Xie and J. Zhang",2019,Usefulness of the heparin-binding protein level to diagnose sepsis and septic shock according to Sepsis-3 compared with procalcitonin and C reactive protein: a prospective cohort study in China,CRP,0.602,0.739,125,0.744,93,32,Sepsis 3.0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,1,0,1,1,1
62,"J. Luo, 2019","J. Luo, W. Jiang, L. Weng, J. Peng, X. Hu, C. Wang, G. Liu, H. Huang and B. Du",2019,Usefulness of qSOFA and SIRS scores for detection of incipient sepsis in general ward patients: A prospective cohort study,qSOFA,0.53,0.87,409,0.5599022,229,180,Sepsis 3.0,1,1,0,0,0,0,0,0,0,1,0,0,1,0,1,1,1,1,1,1
62,"J. Luo, 2019","J. Luo, W. Jiang, L. Weng, J. Peng, X. Hu, C. Wang, G. Liu, H. Huang and B. Du",2019,Usefulness of qSOFA and SIRS scores for detection of incipient sepsis in general ward patients: A prospective cohort study,SIRS,0.98,0.18,409,0.5599022,229,180,Sepsis 3.0,1,1,0,0,0,0,0,0,0,1,0,0,1,0,1,1,1,1,1,1
63,"Gao L, 2018","Gao L, 2018",2018,"DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin.",CRP,0.6692,0.5082,50,0.46,23,27,sepsis vs. SSh,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,1,1,1,1,1
63,"Gao L, 2018","Gao L, 2018",2018,"DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin.",LBP,0.5923,0.541,70,0.714285714,50,20,non-infected vs. sepsis/SSh,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,1,1,1,1,1
63,"Gao L, 2018","Gao L, 2018",2018,"DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin.",PCT,0.7154,0.7213,70,0.714285714,50,20,non-infected vs. sepsis/SSh,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,1,1,1,1,1
64,"Yunus I, 2018","Yunus I, 2018",2018,"The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics",PCT,0.63,0.65,364,0.184065934,67,297,SSh vs non-SSh,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,1,1
65,"Garca de Guadiana Romualdo, 2018","[Garc?a de Guadiana Romualdo, 2018 #1703]",2018,Diagnostic accuracy of lipopolysaccharide-binding protein for sepsis in patients with suspected infection in the emergency department,PCT,0.796,0.774,102,0.480392157,49,53,sepsis vs non-sepsis,0,0,1,0,1,0,0,0,0,0,1,1,1,0,0,1,1,1,1,1
65,"Garca de Guadiana Romualdo, 2018","[Garc?a de Guadiana Romualdo, 2018 #1703]",2018,Diagnostic accuracy of lipopolysaccharide-binding protein for sepsis in patients with suspected infection in the emergency department,CRP,0.571,0.811,102,0.480392157,49,53,sepsis vs non-sepsis,0,0,1,0,1,0,0,0,0,0,1,1,1,0,0,1,1,1,1,1
65,"Garca de Guadiana Romualdo, 2018","[Garc?a de Guadiana Romualdo, 2018 #1703]",2018,Diagnostic accuracy of lipopolysaccharide-binding protein for sepsis in patients with suspected infection in the emergency department,LBP,0.674,0.66,102,0.480392157,49,53,sepsis vs non-sepsis,0,0,1,0,1,0,0,0,0,0,1,1,1,0,0,1,1,1,1,1
66,"J. J?ms?, 2018","J. J?ms?, T. Ala-Kokko, V. Huotari, P. Ohtonen, E. R. Savolainen and H. Syrj?l?",2018,"Neutrophil CD64, C-reactive protein, and procalcitonin in the identification of sepsis in the ICU - Post-test probabilities",PCT,0.96,0.79,39,0.641025641,25,14,Sepsis 3.0,0,1,0,1,0,0,0,0,0,0,1,0,1,0,0,1,1,1,1,1
66,"J. J?ms?, 2018","J. J?ms?, T. Ala-Kokko, V. Huotari, P. Ohtonen, E. R. Savolainen and H. Syrj?l?",2018,"Neutrophil CD64, C-reactive protein, and procalcitonin in the identification of sepsis in the ICU - Post-test probabilities",CRP,0.56,0.93,42,0.642857143,27,15,Sepsis 3.0,0,1,0,1,0,0,0,0,0,0,1,0,1,0,0,1,1,1,1,1
66,"J. J?ms?, 2018","J. J?ms?, T. Ala-Kokko, V. Huotari, P. Ohtonen, E. R. Savolainen and H. Syrj?l?",2018,"Neutrophil CD64, C-reactive protein, and procalcitonin in the identification of sepsis in the ICU - Post-test probabilities",CD64,1,0.93,42,0.642857143,27,15,Sepsis 3.0,0,1,0,1,0,0,0,0,0,0,1,0,1,0,0,1,1,1,1,1
67,"S. Spoto, 2018","S. Spoto, E. Cella, M. De Cesaris, L. Locorriere, S. Mazzaroppi, E. Nobile, A. M. Lanotte, L. Pedicino, M. Fogolari, S. Costantino, G. Dicuonzo, M. Ciccozzi and S. Angeletti",2018,Procalcitonin and MR-Proadrenomedullin Combination with SOFA and qSOFA Scores for Sepsis Diagnosis and Prognosis: A Diagnostic Algorithm,PCT,0.55,0.98,159,0.685534591,109,50,Sepsis 3.0,1,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,1,1,1,1
68,"Tavladaki T, 2017 (S3)","Tavladaki T, 2017 (S3)",2017,"Similar Metabolic, Innate Immunity, and Adipokine Profiles in Adult and Pediatric Sepsis Versus Systemic Inflammatory Response Syndrome-A Pilot Study",CRP,0.75,0.72,46,0.5,23,23,non-infectious SIRS/sepsis vs. ss/sh,0,1,0,1,0,0,0,0,0,0,1,0,1,0,0,1,1,1,1,1
69,"Karon BS, 2017","Karon BS, 2017",2017,"Evaluation of lactate, white blood cell count, neutrophil count, procalcitonin and immature granulocyte count as biomarkers for sepsis in emergency department patients",PCT,0.727,0.817,71,0.507042254,36,35,non-infected vs. SS/SSh,0,1,1,0,0,0,1,0,0,0,0,0,1,0,0,1,1,1,1,1
70,"Ljungstrom1 L, 2017","Ljungstrom1 L, 2017",2017,"Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis",CRP,0.564,0.494,1572,0.356234097,560,1012,non-infectious SIRS/sepsis vs. SS/SSh,1,0,1,0,0,0,1,0,0,0,1,0,1,1,1,1,1,1,1,1
70,"Ljungstrom1 L, 2017","Ljungstrom1 L, 2017",2017,"Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis",PCT,0.321,0.895,1572,0.356234097,560,1012,non-infectious SIRS/sepsis vs. SS/SSh,1,0,1,0,0,0,1,0,0,0,1,0,1,1,1,1,1,1,1,1
71,"J. M. Williams, 2017","J. M. Williams, J. H. Greenslade, J. V. McKenzie, K. Chu, A. F. T. Brown and J. Lipman",2017,"Systemic Inflammatory Response Syndrome, Quick Sequential Organ Function Assessment, and Organ Dysfunction: Insights From a Prospective Database of ED Patients With Infection",SIRS,0.721,0.61,8871,0.244166385,2166,6705,Sepsis 3.0,1,0,1,0,0,0,0,1,0,0,0,0,1,0,1,1,1,1,1,1
71,"J. M. Williams, 2017","J. M. Williams, J. H. Greenslade, J. V. McKenzie, K. Chu, A. F. T. Brown and J. Lipman",2017,"Systemic Inflammatory Response Syndrome, Quick Sequential Organ Function Assessment, and Organ Dysfunction: Insights From a Prospective Database of ED Patients With Infection",qSOFA,0.297,0.961,8871,0.244166385,2166,6705,Sepsis 3.0,1,0,1,0,0,0,0,1,0,0,0,0,1,0,1,1,1,1,1,1
72,"H. K. Park, 2017","H. K. Park, W. Y. Kim, M. C. Kim, W. Jung and B. S. Ko",2017,Quick sequential organ failure assessment compared to systemic inflammatory response syndrome for predicting sepsis in emergency department,qSOFA,0.35,0.99,1009,0.621407334,627,382,organ failure of Sepsis 1.0,1,1,1,0,0,0,0,1,0,1,0,0,1,0,0,1,1,1,1,1
73,"M. Kim, 2017","M. Kim, S. Ahn, W. Y. Kim, C. H. Sohn, D. W. Seo, Y. S. Lee and K. S. Lim",2017,"Predictive performance of the quick Sequential Organ Failure Assessment score as a screening tool for sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia",qSOFA,0.14,0.98,615,0.162601626,100,515,Sepsis 3.0,1,0,0,1,0,0,0,1,0,1,0,0,1,0,1,1,1,1,1,1
74,"E. J. Giamarellos-Bourboulis, 2017","E. J. Giamarellos-Bourboulis, T. Tsaganos, I. Tsangaris, M. Lada, C. Routsi, D. Sinapidis, M. Koupetori, M. Bristianou, G. Adamis, K. Mandragos, G. N. Dalekos, I. Kritselis, G. Giannikopoulos, I. Koutelidakis, M. Pavlaki, E. Antoniadou, G. Vlachogiannis, V. Koulouras, A. Prekates, G. Dimopoulos, A. Koutsoukou, I. Pnevmatikos, A. Ioakeimidou, A. Kotanidou, S. E. Orfanos, A. Armaganidis and C. Gogos",2017,Validation of the new Sepsis-3 definitions: proposal for improvement in early risk identification,qSOFA,0.608,0.872,1063,0.911571025,969,94,Sepsis 3.0,1,1,0,1,0,0,0,1,0,0,1,0,1,0,1,1,1,1,1,1
75,"Askim, 2017","?. Askim, F. Moser, L. T. Gustad, H. Stene, M. Gundersen, B. O. ?svold, J. Dale, L. P. Bj?rnsen, J. K. Dam?s and E. Sollig?rd",2017,Poor performance of quick-SOFA (qSOFA) score in predicting severe sepsis and mortality - a prospective study of patients admitted with infection to the emergency department,SIRS,0.74,0.72,1535,0.070358306,108,1427,severe sepsis of Sepsis 2.0,1,0,1,0,1,0,0,1,0,0,1,0,1,0,1,1,1,1,1,1
75,"Askim, 2017","?. Askim, F. Moser, L. T. Gustad, H. Stene, M. Gundersen, B. O. ?svold, J. Dale, L. P. Bj?rnsen, J. K. Dam?s and E. Sollig?rd",2017,Poor performance of quick-SOFA (qSOFA) score in predicting severe sepsis and mortality - a prospective study of patients admitted with infection to the emergency department,qSOFA,0.32,0.98,1535,0.070358306,108,1427,severe sepsis of Sepsis 2.0,1,0,1,0,1,0,0,1,0,0,1,0,1,0,1,1,1,1,1,1
76,"Ali FT, 2016 (S3)","Ali FT, 2016 (S3)",2016,Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis.,CRP,0.424,0.833,51,0.647058824,33,18,non-infectious SIRS/sepsis vs. SS,0,1,0,1,0,0,1,0,0,0,0,0,1,0,0,1,1,1,1,1
76,"Ali FT, 2016 (S3)","Ali FT, 2016 (S3)",2016,Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis.,PCT,0.606,0.889,51,0.647058824,33,18,non-infectious SIRS/sepsis vs. SS,0,1,0,1,0,0,1,0,0,0,0,0,1,0,0,1,1,1,1,1
76,"Ali FT, 2016 (S3)","Ali FT, 2016 (S3)",2016,Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis.,presepsin,0.697,0.833,51,0.647058824,33,18,non-infectious SIRS/sepsis vs. SS,0,1,0,1,0,0,1,0,0,0,0,0,1,0,0,1,1,1,1,1
77,"Klouche K, 2016 (S3)","Klouche K, 2016 (S3)",2016,Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients.,PCT,0.8,0.59,144,0.694444444,100,44,non-SS/SSh vs. SS/Sh,0,1,0,1,1,0,0,0,0,0,1,0,1,1,0,1,1,1,1,1
77,"Klouche K, 2016 (S3)","Klouche K, 2016 (S3)",2016,Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients.,presepsin,0.9,0.55,144,0.694444444,100,44,non-SS/SSh vs. SS/Sh,0,1,0,1,0,0,1,0,0,0,1,0,1,1,0,1,1,1,1,1
78,"Enguix-Armada A, 2016 (S3)","Enguix-Armada A, 2016 (S3)",2016,"Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.",CRP,0.921,0.795,388,0.634020619,246,142,non-SS/SSh vs. SS/Sh,1,1,0,1,0,0,1,0,0,0,1,0,0,0,0,1,1,1,1,1
78,"Enguix-Armada A, 2016 (S3)","Enguix-Armada A, 2016 (S3)",2016,"Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.",PCT,0.922,0.968,388,0.634020619,246,142,non-SS/SSh vs. SS/Sh,1,1,0,1,0,0,1,0,0,0,1,0,0,0,0,1,1,1,1,1
78,"Enguix-Armada A, 2016 (S3)","Enguix-Armada A, 2016 (S3)",2016,"Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.",presepsin,0.819,0.965,388,0.634020619,246,142,non-SS/SSh vs. SS/Sh,1,1,0,1,0,0,1,0,0,0,1,0,0,0,0,1,1,1,1,1
